BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma
![BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106519714,imgsize-13300,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/bdr-pharmaceuticals-introduces-prostate-cancer-treatment-drug-in-oral-solution-form.jpg)
New Delhi: BDR Pharmaceuticals on Tuesday said it has introduced Enzalutamide oral solution for treatment of prostate cancer, claiming to ...
Read more
US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma
![US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106515457,imgsize-15034,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/us-fda-approvals-bounce-back-in-2023-sparking-hopes-of-a-biotech-recovery.jpg)
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent more novel drugs in 2023 than in 2022, ...
Read more
Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma
![Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106509034,imgsize-12156,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/glenmark-launches-biosimilar-of-anti-diabetic-drug-liraglutide-in-india.jpg)
Mumbai: Glenmark Pharmaceuticals Ltd has launched a biosimilar of the anti-diabetic drug Liraglutide for the first time in India, The ...
Read more
Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma
![Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106504659,imgsize-12854,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/novartis-signs-gene-therapy-deal-with-voyager-for-100-mln-upfront.jpg)
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more
Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma
![Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106504659,imgsize-12854,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/novartis-signs-gene-therapy-deal-with-voyager-for-100-mln-upfront.jpg)
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more
Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma
![Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106358169,imgsize-10134,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/cell-and-gene-therapy-to-have-greatest-impact-on-pharmaceutical-industry-in-2024-globaldata.jpg)
London: Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on ...
Read more
2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma
![2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma 2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106354547,imgsize-44646,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/2023-has-been-pivotal-for-jb-pharma-nikhil-chopra.jpg)
New Delhi : Nikhil ChopraCEO & Whole Time Director, JB Pharma spoke to ETHealthworld’s Prathiba Raju about how 2023 has ...
Read more
IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma
![IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106353476,imgsize-1546360,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/iil-to-invest-rs-700-crore-on-it-greenfield-veterinary-vaccine-facility-in-hyderabads-genome-valley.jpg)
Hyderabad: Indian Immunologicals Limited ,IIL) on Thursday announced that it has started construction of its new greenfield veterinary vaccine facility ...
Read more
US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma
![US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106353262,imgsize-22840,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/us-fda-places-clinical-hold-on-iovances-lung-cancer-treatment-trial.jpg)
New Delhi: The US Food and Drug Administration has placed a clinical hold on iovance Biotherapeutics’ lung cancer therapy trial ...
Read more